FDA Inspection 846761 — SpecGx LLC

SpecGx LLC — FEI 1317295

The FDA completed an inspection of SpecGx LLC on Aug 30, 2013 in Hobart, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 30, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Hobart, NY (United States)

Citations

IDCFRDescription
135821 CFR 211.100(b)SOPs not followed / documented
144821 CFR 211.111Establishment of time limitations
357021 CFR 211.100(a)Approval and review of procedures

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.